SEC Form 4 · accession 0001127602-18-003616
CONMED Corp · CNMD
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Jo Ann Golden
Director
Period of report
Feb 1, 2018
Accepted (ET)
Feb 2, 2018 · 3:42 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000816956
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Feb 1, 2018 | S | 3,000 | $63.898 | D | 16,782 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $63.88 to $63.94. Full information regarding the number of shares sold at each price will be provided upon request of the commission staff, ConMed, or a ConMed security holder.